FDA Inspection
University of Southern California, DBA USC Molecular Imaging CenterUniversity of Southern California, DBA USC Molecular Imaging Center – FDA Inspection, Dec 2, 2016
Record Details
This FDA Inspection record concerns University of Southern California, DBA USC Molecular Imaging Center, with an inspection on December 2, 2016, issued by the Los Angeles District Office, covering human drugs.
- Inspection Date
- December 2, 2016
- Product Type
- Human Drugs
View Company Profile
ID · 96c8af0c-fce7-4d4a-bbd7-b4b74e809691
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 996141
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 212.30(b)Equipment not clean
- 21 CFR 212.50(b)Master Production and Control Records
- 21 CFR 212.60(e)Equipment
- 21 CFR 212.60(g)(3)Complete record of all laboratory test data
- 21 CFR 212.70(b)Compendial test procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University of Southern California, DBA USC Molecular Imaging Center
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2019 | VAI | Los Angeles District Office | Generic Drug Evaluation |
| August 9, 2018 | Not classified | Los Angeles District Office |
Other documents for University of Southern California, DBA USC Molecular Imaging Center
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.